New drug fabhalta under safety watch for rare blood disorder
NCT ID NCT06606314
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 132 people with PNH who are taking Fabhalta to see how safe it is and what side effects occur. Researchers will monitor infections and check for serious red blood cell breakdown if the drug is stopped. The goal is to better understand the drug's risks in everyday use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Handa, Aichi-ken, 475-0817, Japan
-
Novartis Investigative Site
Nagoya, Aichi-ken, 453-8511, Japan
-
Novartis Investigative Site
Nagoya, Aichi-ken, 466-8650, Japan
-
Novartis Investigative Site
Okazaki, Aichi-ken, 444-8553, Japan
-
Novartis Investigative Site
Toyohashi, Aichi-ken, 441-8570, Japan
-
Novartis Investigative Site
Toyota, Aichi-ken, 470-0343, Japan
-
Novartis Investigative Site
Toyota, Aichi-ken, 471-8513, Japan
-
Novartis Investigative Site
Hachinohe, Aomori, 0391104, Japan
-
Novartis Investigative Site
Chiba, Chiba, 2608677, Japan
-
Novartis Investigative Site
Funabashi, Chiba, 273-8556, Japan
-
Novartis Investigative Site
Kashiwa, Chiba, 277-8567, Japan
-
Novartis Investigative Site
Narita, Chiba, 286-8523, Japan
-
Novartis Investigative Site
Matsuyama, Ehime, 790-8524, Japan
-
Novartis Investigative Site
Fukuoka, Fukuoka, 810-8563, Japan
-
Novartis Investigative Site
Kurume, Fukuoka, 830-8543, Japan
-
Novartis Investigative Site
Aizu-Wakamatsu, Fukushima, 9693482, Japan
-
Novartis Investigative Site
Kohriyama, Fukushima, 963-8022, Japan
-
Novartis Investigative Site
Maebashi, Gunma, 371-0811, Japan
-
Novartis Investigative Site
Fukuyama, Hiroshima, 720-0001, Japan
-
Novartis Investigative Site
Hakodate, Hokkaido, 0410821, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 0030006, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 0640804, Japan
-
Novartis Investigative Site
Amagasaki, Hyōgo, 660-8511, Japan
-
Novartis Investigative Site
Ashiya, Hyōgo, 659-0012, Japan
-
Novartis Investigative Site
Himeji, Hyōgo, 670-8540, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 6500047, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 651-0072, Japan
-
Novartis Investigative Site
Nishinomiya, Hyōgo, 662-0918, Japan
-
Novartis Investigative Site
Nishinomiya, Hyōgo, 6638501, Japan
-
Novartis Investigative Site
Tsukuba, Ibaraki, 300-2622, Japan
-
Novartis Investigative Site
Tsukuba, Ibaraki, 3058576, Japan
-
Novartis Investigative Site
Tsukuba, Ibaraki, Ibaraki, Japan
-
Novartis Investigative Site
Morioka, Iwate, 0200066, Japan
-
Novartis Investigative Site
Sakaidechō, Kagawa-ken, 762-8550, Japan
-
Novartis Investigative Site
Kanoya, Kagoshima-ken, 893-0024, Japan
-
Novartis Investigative Site
Isehara, Kanagawa, 259-1193, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 232-0024, Japan
-
Novartis Investigative Site
Kumamoto, Kumamoto, 860-8556, Japan
-
Novartis Investigative Site
Kyoto, Kyoto, 603-8151, Japan
-
Novartis Investigative Site
Uji, Kyoto, 611-0042, Japan
-
Novartis Investigative Site
Ōsaki, Miyagi, 989-6183, Japan
-
Novartis Investigative Site
Miyazaki, Miyazaki, 880-8510, Japan
-
Novartis Investigative Site
Nobeoka, Miyazaki, 882-0835, Japan
-
Novartis Investigative Site
Matsumoto, Nagano, 3908621, Japan
-
Novartis Investigative Site
Nagano, Nagano, 3808582, Japan
-
Novartis Investigative Site
Suwa, Nagano, 392-8510, Japan
-
Novartis Investigative Site
Ōmura, Nagasaki, 856-8562, Japan
-
Novartis Investigative Site
Ikoma, Nara, 630-0293, Japan
-
Novartis Investigative Site
Nagaoka, Niigata, 940-2085, Japan
-
Novartis Investigative Site
Beppu, Oita Prefecture, 874-0840, Japan
-
Novartis Investigative Site
Uruma, Okinawa, 904-2293, Japan
-
Novartis Investigative Site
Habikino, Osaka, 583-0872, Japan
-
Novartis Investigative Site
Izumi, Osaka, 594-0071, Japan
-
Novartis Investigative Site
Moriguchi, Osaka, 570-8540, Japan
-
Novartis Investigative Site
Suita, Osaka, 565-0871, Japan
-
Novartis Investigative Site
Saga, Saga-ken, 849-8501, Japan
-
Novartis Investigative Site
Fukaya, Saitama, 366-0052, Japan
-
Novartis Investigative Site
Kawagoe, Saitama, 3508550, Japan
-
Novartis Investigative Site
Tokorozawa, Saitama, 359-0037, Japan
-
Novartis Investigative Site
Hikone, Shiga, 522-0057, Japan
-
Novartis Investigative Site
Ōtsu, Shiga, 520-0804, Japan
-
Novartis Investigative Site
Rittō, Shiga, 520-3046, Japan
-
Novartis Investigative Site
Iwata, Shizuoka, 438-8550, Japan
-
Novartis Investigative Site
Shimotsuga Gun, Tochigi, 3210293, Japan
-
Novartis Investigative Site
Shimotsuke, Tochigi, 329-0498, Japan
-
Novartis Investigative Site
Utsunomiya, Tochigi, 321-0974, Japan
-
Novartis Investigative Site
Bunkyo Ku, Tokyo, 1138431, Japan
-
Novartis Investigative Site
Higashimurayama, Tokyo, 189-8511, Japan
-
Novartis Investigative Site
Itabashi Ku, Tokyo, 1738606, Japan
-
Novartis Investigative Site
Itabashi-ku, Tokyo, 1738610, Japan
-
Novartis Investigative Site
Meguro City, Tokyo, 153-8581, Japan
-
Novartis Investigative Site
Minato-ku, Tokyo, 105-8471, Japan
-
Novartis Investigative Site
Nerima City, Tokyo, 113-0033, Japan
-
Novartis Investigative Site
Nerima City, Tokyo, 179-0072, Japan
-
Novartis Investigative Site
Ōta-ku, Tokyo, 1438541, Japan
-
Novartis Investigative Site
Shibuya City, Tokyo, 150-8935, Japan
-
Novartis Investigative Site
Shinagawa Ku, Tokyo, 1418625, Japan
-
Novartis Investigative Site
Shinagawa-ku, Tokyo, 1428666, Japan
-
Novartis Investigative Site
Shinjuku Ku, Tokyo, 160-0023, Japan
-
Novartis Investigative Site
Toyama, Toyama, 930-0859, Japan
-
Novartis Investigative Site
Tanabe, Wakayama, 646-8588, Japan
-
Novartis Investigative Site
Kofu, Yamanashi, 400-8506, Japan
-
Novartis Investigative Site
Fukushima, 9601295, Japan
-
Novartis Investigative Site
Ishikawa, 9208641, Japan
-
Novartis Investigative Site
Kagoshima, 892-0853, Japan
-
Novartis Investigative Site
Kyoto, 604-8845, Japan
-
Novartis Investigative Site
Kyoto, 6068507, Japan
-
Novartis Investigative Site
Niigata, 9518520, Japan
-
Novartis Investigative Site
Okayama, 7008558, Japan
-
Novartis Investigative Site
Osaka, 542-0081, Japan
-
Novartis Investigative Site
Shizuoka, 422-8527, Japan